Oncology & Cancer
Mutational signatures may ID pts with Br Ca most likely to benefit from platinum-based chemo
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
Dec 19, 2017
0
3
